Our team

Aris Kekedjan

Aris Kekedjan is a corporate executive and deal leader with extensive global experience across the corporate lifecycle, diverse sectors, and complex transactions.

Chief Investment Officer, General Electric Company (NYSE: GE)

As Chief Investment Officer and Global Head of Business Development, Aris had responsibility across a broad global portfolio of businesses (GE Healthcare, GE Power, GE Renewable Energy, GE Aviation, GE Digital, and GE Capital). He has closed multi-billion-dollar transactions in the Water Technology, Distributed Power, Industrial Automation/IOT, Aerospace and Healthcare industries. He also executed a series of landmark industrial mergers, including Baker-Hughes (NYSE: BKR) and Wabtec (NYSE: WAB) and orchestrated the corporate restructuring of GE Capital, one of the largest corporate restructuring efforts in history.

Chief Executive Officer, Carl Icahn Holdings (NASDAQ: IEP)

Experience

Board Member, Stratasys (NASDAQ: SSYS)

Board of Directors, FinServ Acquisition Corp

Chief Executive Officer, Trinity Biotech (NASDAQ: TRIB)

Board of Directors, XEROX (NASDAQ: XRX)

Founding Partner,

Operations Lead

Expertise:

C-Level Leadership and Board Advisory (across full-life cycle of companies)

M&A, Restructuring
Deal structuring

Board of Directors, XPO Logistics (NYSE: XPO)

Don Ewer

An experienced Private Investor and former Hedge fund Executive with an extensive experience across the capital stack and a wide range of sectors and transactions

Portfolio Manager at Citadel LLC / BTG Pactual / Caxton / Segantii

Donald has spent 29 years managing institutional investment portfolios primarily investing in credit and special situations. He has previously been based in London, New York, Hong Kong and Singapore and is currently based in Oxford U.K

Prior to retuning to Oxford from Asia he was managing a portfolio for Citadel that included $4 billion of private credit investments across Asia. He was ranked in the top 5 investors in Asia by the Asset journal for credit - circa 8 years running.

He has managed assets for multiple large sovereign wealth funds and pension plans over a long period of time: GIC, Temasek, Saudi PIFS, Kuwait PIFS, OTPP, Texas County District retirement pension plan, Shell…Deep contacts with many central banks and finance ministries across Asia, Middle East and Africa

Experience

Donald serves on the boards of Etcembly , VX Pharma and Evolvere biosciences and advises several other companies in the broader life sciences, auto immune and oncology space many with a significant exposure to AI / Data science. He is invested in numerous life science companies in USA, Asia and the UK.

In 2021 he invested in VX Pharma based in South Africa which has strategic relationships with the Aurum Institute (largest NGO in Africa, backed by Gates, WHO etc). The venture is involved in clinical trials across multiple indications in Africa. Roughly 46 trials a year are ongoing,

Private Investor (focus on Healthcare & Life Sciences)

Founding Partner,

Credit Lead

Expertise:

Public / Private Credit / Equity,

Emerging Markets,

Sr. Board Advisory

Deal structuring,

Restructuring,

M&A

Our Advisors

Our Venture Partners

Coming soon

_______________________________________________________

Category title

Write a short description of this category

Category title

Write a short description of this category

Category title

Write a short description of this category